title: Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.
abstract: Infection of cells with flaviviruses in vitro is reduced by pretreatment with small amounts of type I interferon (IFN-alpha/beta). Similarly, pretreatment of animals with IFN and experiments using mice defective in IFN signaling have indicated a role for IFN in controlling flavivirus disease in vivo. These data, along with findings that flavivirus-infected cells block IFN signaling, suggest that flavivirus infection can trigger an IFN response. To investigate IFN gene induction by the very first cells infected during in vivo infection with the flavivirus West Nile virus (WNV), we infected mice with high-titer preparations of WNV virus-like particles (VLPs), which initiate viral genome replication in cells but fail to spread. These studies demonstrated a brisk production of IFN in vivo, with peak levels of over 1,000 units/ml detected in sera between 8 and 24 h after inoculation by either the intraperitoneal or footpad route. The IFN response was dependent on genome replication, and WNV genomes and WNV antigen-positive cells were readily detected in the popliteal lymph nodes (pLN) of VLP-inoculated mice. High levels of IFN mRNA transcripts and functional IFN were also produced in VLP-inoculated IFN regulatory factor 3 null (IRF3(-/-)) mice, indicating that IFN production was independent of the IRF3 pathways to IFN gene transcription, consistent with the IFN type produced (predominantly alpha).
authors.affiliation: Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555-0436, USA.
authors.forename: Nigel
authors.initials: N
authors.lastname: Bourne
authors.forename: Frank
authors.initials: F
authors.lastname: Scholle
authors.forename: Maria Carlan
authors.initials: MC
authors.lastname: Silva
authors.forename: Shannan L
authors.initials: SL
authors.lastname: Rossi
authors.forename: Nathan
authors.initials: N
authors.lastname: Dewsbury
authors.forename: Barbara
authors.initials: B
authors.lastname: Judy
authors.forename: Juliana B
authors.initials: JB
authors.lastname: De Aguiar
authors.forename: Megan A
authors.initials: MA
authors.lastname: Leon
authors.forename: D Mark
authors.initials: DM
authors.lastname: Estes
authors.forename: Rafik
authors.initials: R
authors.lastname: Fayzulin
authors.forename: Peter W
authors.initials: PW
authors.lastname: Mason
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000032:analysis; D004195:Disease Models, Animal; D015870:Gene Expression; D050838:Interferon Regulatory Factor-3 / Q000235:genetics / Q000276:immunology; D007370:Interferon Type I / Q000096:biosynthesis* / Q000097:blood / Q000276:immunology; D008198:Lymph Nodes / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D012333:RNA, Messenger / Q000096:biosynthesis; D014901:West Nile Fever / Q000276:immunology*; D014902:West Nile virus / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D050838:Interferon Regulatory Factor-3; D007370:Interferon Type I; C494233:Irf3 protein, mouse; D012333:RNA, Messenger